Robert O. Fullinfaw

461 total citations
14 papers, 258 citations indexed

About

Robert O. Fullinfaw is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Robert O. Fullinfaw has authored 14 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Ophthalmology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Infectious Diseases. Recurrent topics in Robert O. Fullinfaw's work include Ocular Infections and Treatments (7 papers), Ocular Surface and Contact Lens (4 papers) and Antifungal resistance and susceptibility (3 papers). Robert O. Fullinfaw is often cited by papers focused on Ocular Infections and Treatments (7 papers), Ocular Surface and Contact Lens (4 papers) and Antifungal resistance and susceptibility (3 papers). Robert O. Fullinfaw collaborates with scholars based in Australia, Ireland and Malaysia. Robert O. Fullinfaw's co-authors include Rowan G. Walker, David M. Francis, Gaston N. King, D. Wiesenfeld, David C. M. Kong, Kay Stewart, Raymond G. Morris, Daoud Al‐Badriyeh, John E. Ray and Graham Jones and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal Of Clinical Periodontology and The Medical Journal of Australia.

In The Last Decade

Robert O. Fullinfaw

14 papers receiving 240 citations

Peers

Robert O. Fullinfaw

PHARM

PHEOH

OPHTH

PPCH

Marta Escribano Spain

David G. Li United States

Zilson Malheiros United States

Hanifah Oswari Indonesia

Khadeeja Mohamed United Kingdom

Sabina Więcek Poland

Charalambos Barbatzas Greece

Sahar Sharif United Kingdom

François Graham Canada

I Sabaté Spain

Marta Escribano Spain

Robert O. Fullinfaw

80 ×0.8

PHARM

60 ×0.7

PHEOH

0 ×0.0

OPHTH

5 ×0.1

PPCH

16 ×0.3

Citations per year, relative to Robert O. Fullinfaw Robert O. Fullinfaw (= 1×) peers Marta Escribano

Countries citing papers authored by Robert O. Fullinfaw

Since Specialization

Citations

This map shows the geographic impact of Robert O. Fullinfaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert O. Fullinfaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert O. Fullinfaw more than expected).

Fields of papers citing papers by Robert O. Fullinfaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert O. Fullinfaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert O. Fullinfaw. The network helps show where Robert O. Fullinfaw may publish in the future.

Co-authorship network of co-authors of Robert O. Fullinfaw

This figure shows the co-authorship network connecting the top 25 collaborators of Robert O. Fullinfaw. A scholar is included among the top collaborators of Robert O. Fullinfaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert O. Fullinfaw. Robert O. Fullinfaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Fullinfaw, Robert O., et al.. (2020). Noninfectious mixed cryoglobulinaemic glomerulonephritis and monoclonal gammopathy of undetermined significance: a coincidental association?. BMC Nephrology. 21(1). 293–293. 3 indexed citations

Brown, Fiona C., et al.. (2017). A mouse model of hereditary coproporphyria identified in an ENU mutagenesis screen. Disease Models & Mechanisms. 10(8). 1005–1013. 6 indexed citations

Neoh, Chin Fen, Elsie Chan, Daoud Al‐Badriyeh, et al.. (2016). Open-Label Study of Absorption and Clearance of 1% Voriconazole Eye Drops. Antimicrobial Agents and Chemotherapy. 60(11). 6896–6898. 13 indexed citations

Jones, Graham, Stewart Bryant, Robert O. Fullinfaw, et al.. (2013). Mass or molar? Recommendations for reporting concentrations of therapeutic drugs. The Medical Journal of Australia. 198(7). 368–369. 5 indexed citations

Yates, Christopher J., Katherine A. Barraclough, Brett McWhinney, et al.. (2013). A Practical Limited Sampling Strategy to Predict Free Prednisolone Exposure and Glycemia in Kidney Transplant Recipients. Therapeutic Drug Monitoring. 36(1). 18–23. 4 indexed citations

Neoh, Chin Fen, et al.. (2011). Penetration of Topically Administered 0.5-Percent Caspofungin Eye Drops into Human Aqueous Humor. Antimicrobial Agents and Chemotherapy. 55(4). 1761–1763. 8 indexed citations

Norris, Ross, Jennifer Martin, John E. Ray, et al.. (2010). Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development. Therapeutic Drug Monitoring. 32(5). 615–623. 31 indexed citations

Neoh, Chin Fen, Hui He, Jian Li, et al.. (2010). Rapid and Sensitive Liquid Chromatography/Mass Spectrometry Assay for Caspofungin in Human Aqueous Humor. Antimicrobial Agents and Chemotherapy. 54(10). 4467–4470. 6 indexed citations

Al‐Badriyeh, Daoud, et al.. (2009). Stability of extemporaneously prepared voriconazole ophthalmic solution. American Journal of Health-System Pharmacy. 66(16). 1478–1483. 22 indexed citations

10.

Al‐Badriyeh, Daoud, et al.. (2009). Prospective Open-Label Study of the Administration of Two-Percent Voriconazole Eye Drops. Antimicrobial Agents and Chemotherapy. 53(7). 3153–3155. 12 indexed citations

11.

Lau, David T. W., et al.. (2008). Penetration of 1% voriconazole eye drops into human vitreous humour: a prospective, open‐label study. Clinical and Experimental Ophthalmology. 37(2). 197–200. 16 indexed citations

12.

Lau, David T. W., et al.. (2008). Chemical Stability of Voriconazole 1% Eye Drops. Journal of Pharmacy Practice and Research. 38(3). 179–182. 4 indexed citations

13.

Morris, Raymond G., Kenneth F. Ilett, Susan E. Tett, et al.. (2002). Cyclosporin Monitoring in Australasia: 2002 Update of Consensus Guidelines. Therapeutic Drug Monitoring. 24(6). 677–688. 20 indexed citations

14.

King, Gaston N., et al.. (1993). Gingival hyperplasia in renal allograft recipients receiving cyclosporin‐A and calcium antagonists. Journal Of Clinical Periodontology. 20(4). 286–293. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact